正月初八，年味尚浓，行走在山东潍坊高密市各大工业园区，已是一派热辣滚烫的抓生产、赶订单的繁 忙景象。 在海宇股份有限公司智能化生产车间，自动化生产线高速运转，机械臂精准地进行着各项操作，工人们 在数字化控制台前认真监控着生产数据。 "目前，公司订单已经排到了6月初。为了保证及时交付，我们正月初八复工后全力冲刺'开门红'。"该 公司副总经理张敏介绍说。 "目前公司员工全部到岗，生产部已科学编制生产计划，统筹调配人力、设备资源，精准梳理订单紧急 程度，优化排产流程，确保生产各环节高效连接，全力保障订单按期交付。"来到山东赛维斯服装科技 有限公司，车间内机器轰鸣，各条生产线满负荷运转，该公司经理潘希钦一边介绍一边记录产线情况。 企业订单饱满、生产忙碌，政府也做足服务与支持。2月23日，高密市2026年新春人才招聘会在文体公 园孚日体育馆举行，50家优质名企提供了上千个优质岗位，覆盖机械制造、纺织服装、数字电商等多个 行业，适配应届毕业生、返乡人才等各类求职群体。高密广播电视台视频号、高密观察抖音号等现场直 播，在线人数超10万人次，线上线下（300959）同步发力，精准匹配用工缺口，为企业稳产满产注 入"强心剂"。 ...

俯瞰长三角区域，一条以创新要素高度集聚、产业分工深度协同为特征的经济轴带清晰显现——东起上 海，西抵南京，串联起多座核心城市，构成被纳入国家战略的沿沪宁产业创新带。普陀区作为上海 的"西大堂"和沪宁发展轴线的起点，正以服务长三角一体化、助力这条产业创新带建设为使命，铺展一 幅以创新为引领、协同并进的画卷。 在产业协作上，我们围绕重点产业图谱，推动形成"链式联盟"。加强伙伴园区合作，推动天地软件园与 南通通州平潮科技创新区平台共建，曹杨街道与镇江扬中市签署共建协议，与扬州、泰州等地多个园区 签署合作协议，加强产业、人才、技术的跨区域互补。位于"创新里"的智康加机器人，立足普陀研发中 心，聚焦康复机器人、脑机接口等前沿方向的研发与产业化，积极整合创新带上的供应链，通过与南 通、常州等地的制造资源协同合作，使研发转化成本降低45%。 在综合服务上，我们于G2高速入城口的信泰中心设立沿沪宁协同创新中心，打造实体化的"一站式"服 务中心，集技术对接、产业交流、企业出海服务等功能于一体。通过举办协同创新日、创新成果交易 会，以及构建"沿沪宁融媒矩阵"，持续扩大区域影响力，加强与沿沪宁经济百强县（市）对接，推动合 作走深走 ...

Core Insights - The accessibility industry focuses on providing services for the elderly and disabled, aiming to eliminate barriers to their daily lives and enhance their quality of life [1][3] - The industry includes a variety of products and services, such as mobility aids, communication devices, and smart technology, catering to different needs and scenarios [1][3] Industry Overview - The accessibility industry is characterized by its social care attributes, demand-driven features, and integration of resources across multiple fields [1] - Key products include rehabilitation aids like prosthetics and wheelchairs, communication tools like Braille software, and smart devices for navigation and monitoring [1] Market Trends - The electric wheelchair market is projected to grow from approximately 49.4 billion yuan in 2020 to about 70.5 billion yuan by 2024, with a compound annual growth rate (CAGR) of 7% [6][7] - The rehabilitation robot market is expected to expand significantly, from 3.7 billion yuan in 2019 to 15.29 billion yuan by 2024, reflecting a CAGR of over 30% [8] Policy Development - The legal framework for the accessibility industry began to take shape in 2023, with the implementation of the "Barrier-Free Environment Construction Law" marking a shift towards a regulated industry [12] - Prior to 2023, policies focused on basic support for disabled individuals and the elderly, with initiatives aimed at promoting rehabilitation and accessibility services [12]

Core Viewpoint - The rehabilitation medical industry in China is undergoing significant transformation driven by technological innovation and a focus on clinical needs, as evidenced by the experiences of young entrepreneurs like Wang Daoyu [1][10]. Group 1: Industry Challenges - The rehabilitation medical industry faced initial challenges such as weak supply and heavy reliance on imports, particularly for high-end rehabilitation robots, which were scarce and expensive [2]. - The core contradiction in the industry was the imbalance between patient rehabilitation needs and the insufficient supply of quality rehabilitation resources, especially products tailored to local clinical scenarios [2]. - The industry is characterized by long development cycles and high investment requirements, with product development taking over four years from research to market launch [4][5]. Group 2: Technological Innovation - The focus of technological innovation has shifted from complex structures to addressing clinical needs, emphasizing the importance of practical solutions for patients [6]. - Innovations include the application of eye-tracking technology for rehabilitation training and AI integration for dynamic adjustment of rehabilitation plans based on patient data [6]. - Full-stack self-research is identified as a key direction for technological innovation, aiming to reduce costs and enhance adaptability through proprietary technology [6]. Group 3: Industry Standards and Collaboration - The establishment of industry standards is crucial for the healthy development of the rehabilitation medical field, as early practitioners played a significant role in drafting relevant standards [7]. - Collaboration among industry, academia, and research institutions is essential for aligning technology development with clinical needs and accelerating the translation of technological achievements [7]. Group 4: Future Trends - The rehabilitation medical industry is expected to extend from institutional settings to home care, with a growing demand for practical home rehabilitation products [8]. - Achieving equal access to rehabilitation services across different regions is a key challenge, with the potential for "robot + IoT" models to provide remote rehabilitation services [9]. - The internationalization of Chinese rehabilitation medical technology is seen as viable, with industry alliances suggested as a means to enhance global competitiveness and market access [9]. Group 5: Entrepreneurial Insights - Patience and adherence to core values are emphasized as essential qualities for those entering the rehabilitation medical field, highlighting the importance of a supportive innovation ecosystem [10]. - The rich innovation resources and supportive policies in regions like Shanghai provide a solid foundation for the development of the rehabilitation medical industry [10].

Core Viewpoint - The rehabilitation industry is viewed as a "golden track" with significant growth potential, driven by brain-computer interface (BCI) technology, which is expected to reshape the industry landscape [1] Group 1: Technological Innovation - The company focuses on three cutting-edge areas: brain-computer interfaces, rehabilitation robots, and AI medical technology, with BCI technology accelerating commercialization [2] - A comprehensive product matrix for rehabilitation robots has been established, with plans to launch 5-6 new products by 2026, including various specialized robots [2][4] - The company has initiated a brain science laboratory and developed five technical platforms to enhance its BCI technology, achieving compatibility between EEG devices and rehabilitation equipment [4] Group 2: Research and Development Investment - The company plans to maintain R&D investment at over 20% of revenue for the next 3-5 years, with more than 30% allocated to frontier technology research [5] - In the first three quarters of 2025, R&D investment reached approximately 49.09 million yuan, a year-on-year increase of 27.67%, accounting for 27.58% of quarterly revenue [5] Group 3: Market Transformation - The company has partnered with over 600 leading hospitals to establish BCI rehabilitation treatment and clinical research centers, enhancing treatment precision and effectiveness [6] - The company is transitioning from passive to active rehabilitation models, leveraging BCI technology to empower various rehabilitation products [6] Group 4: International Expansion - The company is accelerating its international market strategy, with overseas sales expected to double in 2024 compared to 2023, aiming for international revenue to account for over 30% by 2030 [7] - The company is pursuing compliance certifications such as EU CE and US FDA to facilitate international market entry and is exploring partnerships and acquisitions to enhance its global presence [7] Group 5: Ecosystem Development - The company is focused on building a comprehensive rehabilitation ecosystem, emphasizing the integration of BCI technology into rehabilitation devices, which is seen as essential for future products [8] - The trend towards lightweight, portable, and home-based rehabilitation devices is expected to drive significant growth in the home rehabilitation market [8] Group 6: Industry Integration - The company plans to strengthen its supply chain for core components and aims to execute 3-5 mergers and acquisitions between 2026 and 2030 to integrate high-growth startups [9] - The company targets to establish chain rehabilitation hospitals featuring BCI and rehabilitation robots, with a goal of achieving over 20% of service revenue by 2030 [9]

Core Viewpoint - The rehabilitation industry is viewed as a "golden track" with significant growth potential, driven by brain-computer interface (BCI) technology, which is expected to reshape the industry landscape [1] Group 1: Technological Innovation - The company focuses on three cutting-edge areas: brain-computer interfaces, rehabilitation robots, and AI medical technology, with BCI technology accelerating commercialization [2] - A comprehensive product matrix in rehabilitation robotics has been established, with plans to launch 5-6 medical device registrations by 2026 [2] - The company has initiated a brain science laboratory and developed five technical platforms to enhance BCI technology integration with rehabilitation equipment [3] - Continuous R&D investment is planned to remain above 20% of revenue over the next 3-5 years, with a significant portion allocated to frontier technology research [4] Group 2: Market Transformation - The company has partnered with over 600 leading hospitals to establish BCI rehabilitation treatment and clinical research centers, aiming to create regional treatment benchmarks [5] - The integration of BCI technology into multi-joint exoskeleton robots and various rehabilitation products is expected to enhance treatment precision and effectiveness [6] - A dual strategy of deepening medical institution engagement while expanding into outpatient markets is being implemented, targeting public hospitals, private hospitals, and rehabilitation institutions [6] Group 3: International Expansion - The company is accelerating its international business, with overseas sales expected to double in 2024 compared to 2023, aiming for international revenue to account for over 30% by 2030 [6][7] - Compliance with international certification standards, such as EU CE and US FDA, is being prioritized to facilitate market entry [7] Group 4: Ecosystem Development - The company is focused on building a comprehensive rehabilitation ecosystem, emphasizing the importance of BCI technology in future rehabilitation devices [8] - The trend towards lightweight, portable, and home-based rehabilitation devices is noted, with a vision to integrate rehabilitation equipment into everyday household items [8] Group 5: Industry Integration - Strengthening the supply chain for core components like chips and sensors is a priority, along with plans for mergers and acquisitions to consolidate industry resources [9] - The company aims to establish chain rehabilitation hospitals featuring BCI and rehabilitation robotics, targeting a service revenue contribution of over 20% by 2030 [9]

Core Viewpoint - Xi'an aims to develop a comprehensive technology-assisted disability support ecosystem through the implementation of the "Implementation Plan for Promoting Technology Assistance for the Disabled" focusing on research, application, and industry development in assistive technology [1][2] Group 1: Technology Development - The city will enhance collaboration among technology, civil affairs, and disability organizations to accurately identify the needs for assistive technology [1] - Key technological advancements will focus on rehabilitation robots, nursing robots, exoskeleton robots, and brain-machine interfaces [1] - Support will be provided for the design and development of smart wheelchairs, rehabilitation aids, and bionic prosthetics to accelerate product research and iteration [1] Group 2: Application and Innovation - Xi'an will promote the application of assistive technology by establishing incubators in development zones and supporting enterprises and academic institutions in creating innovation platforms [2] - Innovative assistive products that meet certain criteria will be prioritized for inclusion in government support programs [2] Group 3: Industry Ecosystem - The city plans to foster collaboration between research institutions and technology companies to expedite the application of assistive technology results [2] - Specialized parks will be developed to encourage innovation among assistive technology enterprises, and leading companies will be supported in forming innovation alliances [2] - A financing channel for assistive technology enterprises and service organizations will be established, and the industry will be included in government industrial guidance funds [2] Group 4: Future Goals - Over the next 3 to 5 years, the plan aims to achieve significant advancements in the development of exoskeleton robots, orthotic devices, brain-machine interfaces, and new biomaterials [2] - By 2030, the goal is to effectively integrate technological innovation with disability services, significantly enhancing the level of intelligent services for the disabled [2]

1月20日晚间，ST赛为（证券代码：300044）发布公告称，预计2025年度期末净资产为负值，在公司2025年年报披露后，公司股票交易可能被实施退市风 险警示（股票简称前冠以"*ST"字样）。 同日晚间，ST赛为还发布了2025年业绩预告。公司预计2025年归母净利润为-10.2亿元至-7.2亿元。 对于业绩亏损幅度扩大及净资产可能为负，ST赛为称，原因在于与深圳市艾特网能技术有限公司（以下简称艾特网能）诉讼、仲裁判决影响，对2025年 度净利润影响约为-7.18 亿元。 回溯公告，ST赛为及子公司廊坊市梅特科技有限公司（以下简称梅特科技）与艾特网能的买卖合同纠纷于2023年12月被深圳国际仲裁院受理，并在近日 作出仲裁判决。深圳国际仲裁院裁决内容包括：ST赛为需向艾特网能支付合同价款6.1279亿元；支付逾期付款违约金（以6.1034亿元为基数按每日万分之 四、以245.45万元为基数按LPR自2022年3月30日起计算至实际清偿日止）；补偿律师费100万元；与梅特科技共同补偿财产保全费5000元、保全保险费 26.87万元，并共同承担仲裁费498.87万元。此外，艾特网能对梅特科技提供抵押的设备在上述债 ...

Core Viewpoint - The rehabilitation industry is viewed as a "golden track" with significant growth potential, and brain-computer interface (BCI) technology is emerging as a disruptive force reshaping the industry landscape [1] Group 1: Technological Innovation - The company focuses on three cutting-edge areas: brain-computer interfaces, rehabilitation robots, and AI medical technology, with BCI technology accelerating commercialization [2] - A comprehensive product matrix in rehabilitation robotics has been established, with plans to launch 5-6 medical device registrations by 2026 [2] - The company has initiated a brain science laboratory and developed five technical platforms to enhance BCI technology integration with rehabilitation equipment [3] - Continuous R&D investment is planned to remain above 20% of revenue over the next 3-5 years, with a significant portion allocated to frontier technology research [4] Group 2: Market Transformation - The company has partnered with over 600 leading hospitals to establish BCI rehabilitation treatment and clinical research centers, enhancing treatment precision and effectiveness [5] - A dual strategy of deepening medical institution engagement and expanding outpatient markets is being implemented, targeting various sectors including private hospitals and rehabilitation institutions [5] - International market expansion is accelerating, with a goal to double overseas sales in 2024 and achieve over 30% of revenue from international markets by 2030 [5][6] Group 3: Ecosystem Development - The company is focused on building a comprehensive rehabilitation ecosystem, emphasizing the importance of BCI technology in future rehabilitation devices [7] - There is a shift towards lightweight, portable, and home-based rehabilitation devices, with a vision to integrate rehabilitation equipment into everyday household items [7] - Industry chain integration is a key strategy for enhancing competitiveness, with plans for mergers and acquisitions to consolidate high-growth startups and expand rehabilitation services [8]

Core Insights - The rehabilitation industry is viewed as a "golden track" with significant growth potential, driven by brain-computer interface (BCI) technology, which is expected to reshape the industry landscape [1][4]. Group 1: Technological Innovation - The company focuses on three cutting-edge areas: brain-computer interfaces, rehabilitation robots, and AI medical technology, with BCI technology accelerating commercialization [1][2]. - A comprehensive product matrix for rehabilitation robots has been established, with plans to obtain medical device registration for 5-6 products by 2026, including various types of therapeutic robots [1][2]. - The company has initiated a dedicated research platform to enhance compatibility between rehabilitation equipment and BCI algorithms, emphasizing the importance of technical collaboration [2]. Group 2: Research and Development Investment - The company plans to maintain R&D investment at over 20% of revenue for the next 3-5 years, with more than 30% allocated to frontier technology research [3]. - In the first three quarters of 2025, R&D investment reached approximately 49.09 million yuan, a year-on-year increase of 27.67%, accounting for 27.58% of quarterly revenue [3]. Group 3: Market Expansion and Strategy - The company has established partnerships with over 600 leading hospitals in China to create centers for BCI rehabilitation treatment and clinical research, enhancing its market penetration [3]. - A dual strategy of deepening relationships with medical institutions while expanding into outpatient markets is being employed, targeting private hospitals, elderly care facilities, and specialized sectors [3][4]. Group 4: International Market Development - The international business of rehabilitation equipment is experiencing rapid growth, with plans to double sales in 2024 compared to 2023 and aim for over 30% of revenue from international markets by 2030 [4]. - The company is working on compliance certifications such as EU CE and US FDA to facilitate international market entry and is exploring partnerships for overseas expansion [4]. Group 5: Ecosystem Development - The company is focused on building a comprehensive rehabilitation ecosystem, leveraging BCI technology as a core driver for industry transformation [4][5]. - There is a shift towards lightweight, portable, and home-based rehabilitation devices, with a vision to integrate rehabilitation equipment into everyday household items [5]. - The company plans to enhance its supply chain for core components and aims to execute 3-5 mergers and acquisitions between 2026 and 2030 to consolidate industry resources [5].